Stay updated on Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPage revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government operating status notice has been removed from the page. All study details, eligibility criteria, and outcomes remain unchanged.SummaryDifference0.4%

- Check40 days agoChange DetectedMinor formatting updates and small text edits are present, with no changes to core study details (title, NCT number, eligibility criteria, outcomes, or current status). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check62 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference4%

- Check69 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.SummaryDifference0.1%

- Check83 days agoChange DetectedThe page now declares Revision: v3.0.2, replacing the previous v3.0.1, indicating a maintenance release. The 'Back to Top' link was removed, a minor UI change.SummaryDifference0.3%

Stay in the know with updates to Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib with Nab-Sirolimus in KRAS G12C NSCLC Clinical Trial page.